0001562180-20-007087.txt : 20201204 0001562180-20-007087.hdr.sgml : 20201204 20201204165717 ACCESSION NUMBER: 0001562180-20-007087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201202 FILED AS OF DATE: 20201204 DATE AS OF CHANGE: 20201204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRODERICK PATRICK A CENTRAL INDEX KEY: 0001233220 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 201370477 MAIL ADDRESS: STREET 1: C/O INTERSECT ENT, INC. STREET 2: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-12-02 false 0001271214 Intersect ENT, Inc. XENT 0001233220 BRODERICK PATRICK A C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false EVP, GC & Corporate Secretary Common Stock 2020-12-02 4 A false 24156.00 0.00 A 24156.00 D Stock Options (Right to buy) 19.89 2020-12-02 4 A false 44989.00 0.00 A 2030-12-01 Common Stock 44989.00 44989.00 D Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of November 30, 2020. Restricted stock units. The vesting commencement date of the option is November 30, 2020. 1/4th of the shares subject to the option shall vest on November 30, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter over 36 months. /s/ Patrick A. Broderick 2020-12-04